ACA Premium Tax Credit Extension Uncertainty and Market Implications
Congress faces a critical decision on the extension of ACA enhanced premium tax credits, impacting millions of insured Americans and the health insurance marketplace.
Congress faces a critical decision on the extension of ACA enhanced premium tax credits, impacting millions of insured Americans and the health insurance marketplace.
Seven major U.S. healthcare corporations avoided $34 billion in taxes after the 2017 tax law while increasing profits and insurance claim denials, with implications for patient care quality and regulatory scrutiny.
Homeowners face rising insurance premiums due to increased climate risks, severe weather, and market shifts. Learn how market reforms and risk mitigation affect coverage costs.
The 2025 cyberattack on Allianz Life affects 1.4 million US customers, raising industry-wide concerns about data privacy, regulatory compliance, and cyber risk management in life and health insurance.
The Ninth Circuit ruled fractional interests in life insurance policies are securities, raising compliance requirements for wealth managers and advisors in the U.S.
Wisconsin shows low adoption of federal flood insurance despite increasing flood risks. This analysis covers NFIP policies, private flood insurance options, and regulatory gaps affecting coverage.
Allianz Life Insurance disclosed a data breach compromising personal information of 1.4 million customers, highlighting cybersecurity challenges in the insurance industry and compliance implications.
ALIRT Research reports on the rapid growth of foreign reinsurance in the U.S. life insurance and annuity sectors, exploring regulatory implications and industry impact.
Allstate reports robust Q2 revenue and net income growth, driven by auto insurance premium increases and improved combined ratios. Regulatory approvals in key states support market stability.
Increasing specialty drug costs lead to greater use of alternative funding programs in employer health plans, raising access and cost concerns amid rising drug prices.